Solyon, generic name amisulpride tablets, has efficacy as an antischizophrenic with side effects including elevated prolactin, weight gain, and extrapyramidal symptoms. Amisulpride tablets are an aniline-substituted psycho-sedative suitable for the treatment of acute and chronic schizophrenia characterized by positive symptoms (hallucinations, delirium, cognitive deficits) and/or negative symptoms (affective apathy, delayed reaction time, social withdrawal), or for schizophrenia in which negative symptoms predominate. Common adverse effects of the drug include elevated prolactin in the blood (breast milk overflow, amenorrhea, impotence, etc.), weight gain, extrapyramidal symptoms (salivation (drooling), inability to sit still, hypertonia, tremor, hypokinesia); rarely, drowsiness, and gastrointestinal dysfunction (constipation, nausea, vomiting, dry mouth). In addition, acute dystonia (symptoms such as eye-turning crisis, clenching of teeth, spasmodic strabismus), delayed dyskinesia (involuntary tongue or face movements), hypotension, bradycardia, allergic reactions, convulsions and other side effects are also rarely seen. Contraindications for use include hypersensitivity to the product, patients with pheochromocytoma, severe renal insufficiency, lactating women, prolactin-dependent patients. Specific medication should be under the guidance of a specialist, not unauthorized use of medication.